ECOP PCO-RL: E2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/07 → 4/30/16

Funding

  • Frontier Science and Technology Research Foundation (PCOE280500 // PCOE280500)
  • Pfizer Inc. (PCOE280500 // PCOE280500)